0001214659-23-006373.txt : 20230502
0001214659-23-006373.hdr.sgml : 20230502
20230502163026
ACCESSION NUMBER: 0001214659-23-006373
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230428
FILED AS OF DATE: 20230502
DATE AS OF CHANGE: 20230502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jackman Stephan
CENTRAL INDEX KEY: 0001864257
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40483
FILM NUMBER: 23879589
MAIL ADDRESS:
STREET 1: C/O ALZAMEND NEURO, INC.
STREET 2: 3802 SPECTRUM BOULEVARD, SUITE 112C
CITY: TAMPA
STATE: FL
ZIP: 33612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alzamend Neuro, Inc.
CENTRAL INDEX KEY: 0001677077
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811822909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 3500 LENOX RD. NE
STREET 2: SUITE 1500
CITY: ATLANTA
STATE: GA
ZIP: 30326
BUSINESS PHONE: 844-722-6333
MAIL ADDRESS:
STREET 1: 3500 LENOX RD. NE
STREET 2: SUITE 1500
CITY: ATLANTA
STATE: GA
ZIP: 30326
4
1
marketforms-61359.xml
PRIMARY DOCUMENT
X0407
4
2023-04-28
0001677077
Alzamend Neuro, Inc.
ALZN
0001864257
Jackman Stephan
3480 PEACHTREE ROAD NE
SECOND FLOOR SUITE 103
ATLANTA
GA
30326
true
true
false
false
Chief Executive Officer
0
Common Stock
2023-04-28
4
P
false
37000
0.5405
A
45500
D
The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.5405. The range of purchase prices on the transaction date was $0.5398 to $0.5499 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
/s/ Stephan Jackman
2023-05-02